Alzheimer’ s disease is very frightening and alarming, however, new research is hopeful. And trials have begun for dementia and Alzheimer’s disease involving CBD and the body’s receptors.
Scientists believe that there is increasing evidence that the endocannabinoid system may be regulating the neurodegenerative processes.
Dementia and Alzheimer’s are age-related dementia associated with impairments in learning and memory accompanied by neuroinflammation, oxidative stress, and neurodegeneration.
Over the past few years, there has been a growing interest in the therapeutic potential of medications that target the endocannabinoid system (ECS).
Every day we are finding out more about the disease and how to prevent it, and possibly change the outcome. More research is becoming available with the research of CBD and this insidious disease.